Ningning Song at Shandong Second Medical University, China.
Dr. Ningning Song is a distinguished microbiologist specializing in bacterial transcriptional regulation and tuberculosis pathogenesis. She has made significant contributions to identifying regulatory proteins involved in the latent and dormant infection stages of M. tuberculosis. Her research on small molecules affecting transcriptional regulation has provided valuable insights into tuberculosis treatment and drug development. Dr. Song has been instrumental in fostering interdisciplinary collaborations, securing patents, and leading pioneering studies in molecular diagnostics.
Publication Profile
Scopus
Educational Details
Dr. Ningning Song holds a Ph.D. in Molecular Biology, specializing in UVB research, from Belgium. Her academic expertise lies in microbiology, with a strong emphasis on transcriptional regulation, bacterial pathogenesis, and molecular diagnostics.
Professional Experience
Dr. Song is a Professor and the leader of the Young Talent Education Innovation Team of Shandong Province. She serves as a Special Expert under the Weifang Yuandu Scholars program and is the Director of the Weifang Key Laboratory of Respiratory Pathogens and Drug Therapy. Over her career, she has successfully led four National Natural Science Foundation projects, published more than 40 research articles, secured six authorized patents, and contributed to two major talent development projects. As an editorial board member for Frontiers in Cellular and Infection Microbiology, she plays a key role in advancing research in her field.
Research Interest
Dr. Song’s research focuses on the transcriptional regulation of Mycobacterium tuberculosis, omics-based screening of virulence factors, and molecular diagnosis of tuberculosis. Her work extends to exploring nanomaterial-based drug delivery systems for drug-resistant bacteria in collaboration with Tianjin University and investigating regulatory mechanisms of M. tuberculosis with the Chinese Academy of Agricultural Sciences.
Author Metrics & Achievements
-
-
Total Research Publications: 42 (SCI, Scopus)
-
Completed/Ongoing Research Projects: 9
-
Patents Published/Under Process: 9
-
Books Published (ISBN): 2
-
Editorial Appointments: Frontiers in Cellular and Infection Microbiology
-
Collaborations: Co-published five articles with Tianjin University and the Chinese Academy of Agricultural Sciences
-
Professional Memberships: Chinese Association for the Defense of Tuberculosis
Top Noted Publication
-
Engineered Nanovesicles for the Precise and Noninvasive Treatment of Deep Osteomyelitis Caused by MRSA Infection with Enhanced Immune Response
Authors: Xingyue Yang, Ren Fang, Xiaotian Li, Yumiao Zhang, Ningning Song
Journal: ACS Applied Materials & Interfaces, 2025
Summary: This study introduces engineered nanovesicles designed for the targeted and noninvasive treatment of deep osteomyelitis caused by MRSA infections. The nanovesicles enhance the immune response, offering a promising therapeutic strategy for challenging bone infections.
-
Novel Target and Cofactor Repertoire for the Transcriptional Regulator JTY_0672 from Mycobacterium bovis BCG
Authors: Hui Wang, Xiaotian Li, Shuxian Wang, Zhaoli Li, Ningning Song
Journal: Frontiers in Microbiology, 2024
Summary: This research identifies new targets and cofactors associated with the transcriptional regulator JTY_0672 in Mycobacterium bovis BCG. The findings provide insights into the bacterial transcriptional regulation mechanisms, contributing to the understanding of mycobacterial gene expression.
Conclusion
Dr. Ningning Song is a highly accomplished microbiologist whose contributions to bacterial transcriptional regulation, tuberculosis pathogenesis, and nanomaterial-based drug delivery make her a strong candidate for the Best Researcher Award. Her strong publication record, leadership roles, patents, and interdisciplinary collaborations position her as a leading researcher in her field. Addressing citation impact, global collaborations, and industry applications could further solidify her standing among top researchers worldwide.